Compare Bio Protocol (BIO) vs Chainbase (C) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Chainbase — how do they compare? Bio Protocol trades at Rp440.77 (market cap Rp998,02M, Rp177,99M 24h volume), while Chainbase trades at Rp1,111 (market cap Rp429,94M, Rp58,69M 24h volume). The key difference: Bio Protocol is far larger — about 2.3× Chainbase's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 387M / 1B C (39%) for Chainbase. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Chainbase for 10 Days on average.
| BIO | C | |
|---|---|---|
Market Cap | Rp998,02M | Rp429,94M |
Volume (24h) | Rp177,99M | Rp58,69M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 387M / 1B C (39%) |
Typical Hold Time | 18 Days | 10 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Chainbase is trading at Rp1,110.843 with a market cap of Rp427.15M, showing bullish technical signals overall. The token is currently in a strong uptrend with moving averages indicating positive momentum, though oscillators are neutral. Key resistance levels are at Rp1,258 and Rp1,298, while support sits at Rp1,151 and Rp1,084. With only 39% of the maximum 1M token supply in circulation and an average hold time of 10 days, the token shows moderate distribution and short-term holding patterns.
Overall outlook remains cautiously optimistic with strong technical momentum but overbought RSI signals suggesting potential near-term consolidation. Major opportunities include the limited token supply and bullish trend structure, while risks include high volatility from low market cap and potential profit-taking pressure given extended RSI readings. Investors should monitor key support levels for entry opportunities.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Chainbase
Chainbase is developing the Hyperdata Network for AI, establishing a foundational layer for the DataFi era. This network converts fragmented on-chain signals into structured, verifiable, and AI-ready data, facilitating seamless collaboration among agents, applications, and humans. Chainbase empowers a decentralized data economy where data is treated as capital—composable, monetizable, and accessible to everyone.
Read more on C →
